Storage and handling
Tamper resistant for your protection. Use only if safety seal is intact.
Regional Allergies Northeastern US
- Manufacturer
- King Bio Inc, | King Bio Inc.
- Effective date
- 2020-07-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:13:15
Label at a glance#
ProductRegional Allergies Northeastern US
Active ingredientADENOSINE CYCLIC PHOSPHATE, EPINEPHRINE, CORTICOTROPIN, HYACINTHOIDES NON-SCRIPTA, ONION, COLLINSONIA CANADENSIS ROOT, CORTISONE ACETATE, EUPHRASIA STRICTA, GALPHIMIA GLAUCA FLOWERING TOP, HISTAMINE DIHYDROCHLORIDE, POTASSIUM CHLORIDE, SUS SCROFA NASAL MUCOSA, SODIUM CHLORIDE, SACCHAROMYCES CEREVISIAE RNA, RUMEX CRISPUS ROOT, SCHOENOCAULON OFFICINALE SEED, SAGE, TANACETUM VULGARE TOP, TRIFOLIUM PRATENSE FLOWER, VINCA MINOR
Label structure9 sections
Contacts and useful links#
Websitewww.drkings.com
www.DrKings.com
www.DrKings.comLabel contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
HPUS active ingredients
Equal volumes of each ingredient in 12X, 30X, and 1LM potencies.
Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Agraphis nutans, Allium cepa, Collinsonia canadensis, Cortisone aceticum, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum, Kali muriaticum, Mucosa nasalis suis, Natrum muriaticum, RNA, Rumex crispus, Sabadilla, Salvia officinalis, Tanacetum vulgare, Trifolium pratense, Vinca minor.
INDICATIONS & USAGE SECTION
Uses for temporary relief of allergy symptoms commonly experienced in CT. DC. DE. MA. ME, MD. NH. NJ. NY. PA. RI. VT.
- itchy, watery eyes
- runny nose
- sneezing
- sore throat
- sinus congestion
- cough
- stuffy nose
- fatigue
- itchy, irritated skin
- hoarseness
- headache
WARNINGS SECTION
Warnings
Stop use and consult a physician if symptoms worsen or
persist for more than 7 days.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a healthcare professional
before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get
medical help or contact a Poison Control Center immediately.
DOSAGE & ADMINISTRATION SECTION
Directions
- Initially, depress pump until primed.
- Spray one dose directly into mouth
- Adults: 3 sprays 3 times per day.
- Children ages 6-12: 2 sprays 3 times per day.
- Consult a physician for use in children under 6 years of age.
- Use additionally as needed, up to 6 times per day.
STORAGE AND HANDLING SECTION
Tamper resistant for your protection. Use only if safety seal is intact.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Bio-Energetically Enhanced™ pure
water, citrus extract* (ascorbic
acid, citric acid, citrus aurantium
amara fruit extract, citrus
aurantium sinensis peel extract,
citrus reticulata fruit extract,
demineralized water, glycerin,
lactic acid), Honeysuckle (Lonicera
japonica), polylysine, Shagbark
Hickory (Carya ovata) Bark
Extract, steviol (Steviol
glycosides).
OTC - PURPOSE SECTION
Drug Facts__________________________________________________________________________________________________________
HPUS active ingredients Purpose
Equal volumes ofeach ingredient in 12X, 30X, and LM1 potencies.
Adenosinum cyclophosphoricum.............................................headache, runny nose
Adrenalinum........................................................................hay fever, swollen sinuses, lung congestion
Adrenocorticotrophin (30X)....................................................congestion, cough
Agraphis nutans....................................................................swollen glands or tonsils
Allium cepa...........................................................................hay fever, sinus headache, sneezing
Collinsonia canadensis............................................................hoarseness, dry cough, runny nose
Cortisone aceticum................................................................allergic reaction, irritability
Euphrasia officinalis...............................................................discharge from eyes and nose
Galphimia glauca...................................................................swollen eyelids, hay fever
Histaminum hydrochloricum....................................................coughing fits, itching throat
Kali muriaticum.....................................................................hoarseness, stuffy nose, nosebleed
Mucosa nasalis suis................................................................sinus headache, nasal congestion
Natrum muriaticum................................................................watery eyes, sneezing
RNA.....................................................................................allergic reactions
Rumex crispus.......................................................................raw throat with much mucus, dry cough
Sabadilla...............................................................................sore throat, runny nose, sneezing fits
Salvia officinalis.....................................................................tickling cough, fever
Tanacetum vulgare.................................................................eye pain, laborious breathing
Trifolium pratense..................................................................choking cough, hoarseness
Vinca minor...........................................................................rapid respiration, spasmodic cough
OTC - QUESTIONS SECTION
Keep carton for complete drug facts
and product information.
Questions? Call 866.298.2740
King Bio, Inc. • 3 Westside Drive
Asheville, NC 28806 USA
FDA Reg. #1053442
For latest product information
and instructions, visit
www.DrKings.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57955-0753-2 | 2022-01-28 | C162847 | 48780-1 | 9d75b9cf-e6a5-f424-e053-dadaa90a57ce | Regional Allergies Northeastern U.S. |
| 57955-8197-2 | 2020-07-08 | C162847 | 48780-1 | 9d75b9cf-e6a5-f424-e053-dadaa90a57ce | Regional Allergies Northeastern U.S. |
| 57955-8197-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-e6a5-f424-e053-dadaa90a57ce | Regional Allergies Northeastern U.S. |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57955-0753-2 | Regional Allergies Northeastern US | 59 mL in 1 BOTTLE, SPRAY | LIQUID | 59 | 3 | |
| 57955-0753-2 | Regional Allergies Northeastern US | 1 in 1 CARTON | LIQUID | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57955-0753 | REGIONAL ALLERGIES NORTHEASTERN US (ADENOSINUM CYCLOPHOSPHORICUM, ADRENALINUM, ADRENOCORTICOTROPHIN, AGRAPHIS NUTANS, ALLIUM CEPA, COLLINSONIA CANADENSIS, CORTISONE ACETICUM, EUPHRASIA OFFICINALIS, GALPHIMIA GLAUCA, HISTAMINUM HYDROCHLORICUM, KALI MURIATICUM, MUCOSA NASALIS SUIS, NATRUM MURIATICUM, RNA, RUMEX CRISPUS, SABADILLA, SALVIA OFFICINALIS, TANACETUM VULGARE, TRIFOLIUM PRATENSE, VINCA MINOR) LIQUID [KING BIO INC,] | 3 | Legacy NDC, 2 package rows | 20200709_9b717c32-7a7c-40e6-8fc3-4ccbb27d30ad.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ADENOSINE CYCLIC PHOSPHATE | ACTIVE INGREDIENT | E0399OZS9N | 1 | |
| COLLINSONIA CANADENSIS ROOT | ACTIVE INGREDIENT | O2630F3XDR | 1 | |
| CORTICOTROPIN | ACTIVE INGREDIENT | K0U68Q2TXA | 1 | |
| CORTISONE ACETATE | ACTIVE INGREDIENT | 883WKN7W8X | 1 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| EUPHRASIA STRICTA | ACTIVE INGREDIENT | C9642I91WL | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE INGREDIENT | 93PH5Q8M7E | 1 | |
| HISTAMINE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3POA0Q644U | 1 | |
| HYACINTHOIDES NON-SCRIPTA | ACTIVE INGREDIENT | 5F658PFU56 | 1 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 1 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| RUMEX CRISPUS ROOT | ACTIVE INGREDIENT | 9N1RM2S62C | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 1 | |
| SAGE | ACTIVE INGREDIENT | 065C5D077J | 1 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE INGREDIENT | 6NAF1689IO | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE INGREDIENT | ID3Z1X61WY | 1 | |
| TANACETUM VULGARE TOP | ACTIVE INGREDIENT | D52957JQ8M | 1 | |
| TRIFOLIUM PRATENSE FLOWER | ACTIVE INGREDIENT | 4JS0838828 | 1 | |
| VINCA MINOR | ACTIVE INGREDIENT | WGM46PQF02 | 1 | |
| ADENOSINE CYCLIC 3',5'-PHOSPHATE | ACTIVE MOIETY | E0399OZS9N | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| COLLINSONIA CANADENSIS ROOT | ACTIVE MOIETY | O2630F3XDR | 1 | |
| CORTICOTROPIN | ACTIVE MOIETY | K0U68Q2TXA | 1 | |
| CORTISONE | ACTIVE MOIETY | V27W9254FZ | 1 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 1 | |
| EUPHRASIA STRICTA | ACTIVE MOIETY | C9642I91WL | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE MOIETY | 93PH5Q8M7E | 1 | |
| HISTAMINE | ACTIVE MOIETY | 820484N8I3 | 1 | |
| HYACINTHOIDES NON-SCRIPTA | ACTIVE MOIETY | 5F658PFU56 | 1 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| RUMEX CRISPUS ROOT | ACTIVE MOIETY | 9N1RM2S62C | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 1 | |
| SAGE | ACTIVE MOIETY | 065C5D077J | 1 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE MOIETY | 6NAF1689IO | 1 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE MOIETY | ID3Z1X61WY | 1 | |
| TANACETUM VULGARE TOP | ACTIVE MOIETY | D52957JQ8M | 1 | |
| TRIFOLIUM PRATENSE FLOWER | ACTIVE MOIETY | 4JS0838828 | 1 | |
| VINCA MINOR | ACTIVE MOIETY | WGM46PQF02 | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Regional Allergies Northeastern US
- Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin, Agraphis nutans, Allium cepa, Collinsonia canadensis, Cortisone aceticum, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum, Kali muriaticum, Mucosa nasalis suis, Natrum muriaticum, RNA, Rumex crispus, Sabadilla, Salvia officinalis, Tanacetum vulgare, Trifolium pratense, Vinca minor
- WATER
- CARYA OVATA BARK
- CITRUS BIOFLAVONOIDS
- LONICERA JAPONICA FLOWER
- POLYEPSILON-LYSINE (4000 MW)
- REBAUDIOSIDE A
- ADENOSINE CYCLIC PHOSPHATE
- EPINEPHRINE
- CORTICOTROPIN
- HYACINTHOIDES NON-SCRIPTA
- ONION
- COLLINSONIA CANADENSIS ROOT
- CORTISONE ACETATE
- CORTISONE
- EUPHRASIA STRICTA
- GALPHIMIA GLAUCA FLOWERING TOP
- HISTAMINE DIHYDROCHLORIDE
- HISTAMINE
- POTASSIUM CHLORIDE
- POTASSIUM CATION
- SUS SCROFA NASAL MUCOSA
- SODIUM CHLORIDE
- CHLORIDE ION
- SACCHAROMYCES CEREVISIAE RNA
- RUMEX CRISPUS ROOT
- SCHOENOCAULON OFFICINALE SEED
- SAGE
- TANACETUM VULGARE TOP
- TRIFOLIUM PRATENSE FLOWER
- VINCA MINOR
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 57955-0753 | 57955-0753-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, COATED / ORAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / ORAL | 269 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / TOPICAL | 4 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GEL / TOPICAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a9ef424c-d84c-b5bc-e053-2995a90aa6f4 | 9b717c32-7a7c-40e6-8fc3-4ccbb27d30ad | 2020-07-08 | Warnings | a9ef424c-d84c-b5bc-e053-2995a90aa6f4 9b717c32-7a7c-40e6-8fc3-4ccbb27d30ad |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.